A Cost-Effectiveness Analysis of Abemaciclib in Combination with Adjuvant Endocrine Therapy for HR+, HER2–, Node-Positive, High-Risk Early Breast Cancer
Titel:
A Cost-Effectiveness Analysis of Abemaciclib in Combination with Adjuvant Endocrine Therapy for HR+, HER2–, Node-Positive, High-Risk Early Breast Cancer
Auteur:
Davie, Alison Traoré, Sory Badreldin, Waleed Torstensson, Astrid Cakar, Esra McCullough, Anuja C. Tempelaar, Susan Fenwick, Elisabeth Hall, Peter S.